Brachytherapy with iridium-192 HDR to prevent from restenosis in peripheral arteries. An update

Herz

Volumn 23, Issue 6, 1998, Pages 394-400

  Liermann, Dieter ^a,c   Kirchner, Johannes ^a   Bauernsachs, Ruppert ^b   Schopohl, Bernhard ^b   Böttcher, Heinz D ^b  

^a ST JOSEF HOSPITAL   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Brachytherapy; Iridium 192; Peripheral arteries; Restenosis

Indexed keywords

IRIDIUM 192;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; FEMALE; HUMAN; LASER SURGERY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RADIATION DOSE; RESTENOSIS; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0031686619     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03043605     Document Type: Article

References (80)

1. Amronin GG, Gildenhorn HC, Solomon RD, et al. The synergism of X irradiation and cholesterol fat feeding on the development of coronary artery lesions. J Atheroscler Res 1964;4:325-34.
2. Artom C, Lofland HB, Clarkson TB. Ionizing radiation, atherosclerosis, and lipid metabolism in pigeons. Radiat Res 1965;26:165-77.
3. Baensch W. Über die Strahlenbehandlung der Keloide. Strahlentherapie 1937;60.204-9.
4. Battegay EJ, Raines EW, Seifert RA, et al. TGF-B induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 1990;63:515-24.
5. Betz E, Hämmerle H, Strohschneider T. Inhibition of smooth muscle cell proliferation and endothelial permeability with fluranizine in vitro and in experimental atheromas. Res Exp Med 1985;325-40.
6. Betz E, Hämmerle H, Strohschneider T. Vergleich von Wirkungen einzelner Pharmaka auf die Proliferation von Gefäßmuskelzellen in vivo und in vitro. In: Fischer H. Betz E, eds. Gefäßwandelemente in vivo und in vitro Stuttgart: Wissenschaftliche Verlagsgesellschaft. 1984;43-57.
7. Brambs HJ, Freund U, Bruggmoser G, et al. Kombinierte intraduktale perkutane Radiotherapie bei malignen Gallengangsobstruktionen mit anschließender prothetischer Versorgung. Onkologie 1987;10:84-9.
8. Castellot Jr JJ, Addonizio ML, Rosenberg R, et al. Cultured endothelial cells produce a heparin like inhibitor of smooth muscle cell growth. J Cell Biol 1990;110:373-9.
9. Clowes AW, Karnovsky MJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 1977;265: 625-6.
10. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. Lab Invest 1983;49:327-34.
11. Courrier JW, Power TK, Haudenschild CC, et al. Low molecular weight heparin (enoaparin) reduces restenosis after iliac angioplasty in the hypercholesterolemic rabbit. J Am Coll Cardiol 1991;17:118-25.
12. Cox JL, Gottlieb AL Restenosis following percutaneous transluminal angioplasty: clinical, physiological and pathological features. Can Med Assoc J 1986;136:1129-32.
13. Craig RDP, Pearson D. Early post-operative irradiation in the treatment of keloid scars. Br J Plast Surg 1965;18:369-75.
14. Crocett DJ. Regional keloid susceptibility. Br J Plast Surg 1964;17:245-53.
15. Cwikiel W, Stridbeck H, Stenram U. Electrolytic stents to inhibit tumor growth. An experimental study in vitro and in rats. Acta Radiol 1993;34:1-5.
16. Dalicho W. Zur Therapie der Keloide mit besonderer Berücksichtigung der Radiumbestrahlung. Stahlentherapie 1949;78.
17. Dartsch PC, Betz E, Ischinger T. Wirkung von Dihämatoporphyrin-Derivaten auf kultivierte glatte Muskelzellen des Menschen aus normalen und atherosklerotisch veränderten Gefäßsegmenten. Übersicht über bisherige Ergebnisse und Implikationen für eine photodynamische Therapie. Z Kardiol 1991;80:6-14.
18. Dichek DA, Neville RF, Zwiebel JA, et al Seeding of intravascular stents with genetically engineered endothelial cells. Circulation 1989;80:1347-53.
19. Drescher W, Basche S, Schumann E. Arterielle Spätkomplikationen nach Strahlentherapie. Strahlentherapie 1984;160:505-7.
20. Ellis SG, Roubin GS, Wilentz J. Results of a randomized trial of heparin and aspirin vs aspirin alone for prevention of acute closure and restenosis after angioplasty (PTCA). Circulation 1987; 76:213.
21. Enhamre A, Hammar H. Treatment of keloids with excision and postoperative x-ray irradiation. Dermatologica 1983;167:90-3.
22. Essed CE, Van Den Brand M, Becker AE. Transluminal coronary angioplasty and early restenosis: fibrocellular occlusion after wall laceration. Br Heart J 1983;49:393-6.
23. Faxon DP, Sanborn TA, Haudenschild CC. Mechanism of angioplasty and its relation to restenosis. Am J Cardiol 1987;60:5B-9B.
24. Faxon DP, Sanborn TA, Weber VJ. Restenosis following transluminal angioplasty in experimental atherosclerosis. Arteriosclerosis 1984;4:189-95.
25. Fischer JJ. Proliferation of rat aortic endothelial cells following X irradiation. Radiat Res 1982;92:405-10.
26. Friedman JR, Burns R. Role of platelets in the proliferative response of the injured artery. Prog Hemost Thromb 1978;4:249-78.
27. Garth EA, Ratliff NB, Hollman J, et al. Intimai proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985;6:369-72.
28. Graul EH. Zur Klinik des Keloids. Strahlentherapie 1955;98: 119-32.
29. Guyton J, Rosenburg R, Clowes A, et al. Inhibition of rat arterial smooth muscle cell proliferation by heparin: in vivo studies with anticoagulant and non anticoagulant heparin. Circ Res 1980;46:625-34.
30. Hagen B. Einflüsse der medikamentösen Nachbehandlung auf die mittelfristigen Ergebnisse von Stent-Implantationen der A. femoropolitea. J Cardiol Vase Intervent Radiol 1994;17.2:65.
31. Hashizume M, Yang Y, Galt S. Intimai response of saphenous vein to intraluminal trauma by simulated angioscopic insertion. J Vasc Surg 1987;5:862-8.
32. Heras, M, Chesebro JH, Penny WJ, et al. Effects of thrombin inhibition on the development of acute platelet thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation 1989;79:657-65.
33. Hirst DG, Denekamp J, Hobson B. Proliferation studies of the endothelial and smooth muscle cells of the mouse mesentery after irradiation. Cell Tissue Kinet 1980;193:91-104.
34. Hoepp LM, Elbadawi M, Cohn M, et al. Steroids and immunosuppression effect on anastomotic intimai hyperplasia femoral arterial dacron bypass grafts. Arch Surg 1979;114:273-6.
35. Hoover R, Rosenburg R, Hearing W, et al. Inhibition of rat arterial smooth cell proliferation by heparin: II in vitro studies. Circ Res 1980;47:578-83.
36. Imparato AM, Bracco A, Kim GE, et al. Intimai and neointimal fibrous proliferation causing failure of arterial reconstructions. Surgery 1972;172:1007-17.
37. Ip JH, Fuster V, Badimon L, et al. Syndromes of acceleration atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990;15:1667-87.
38. Johnson AG. Large artery damage after X-radiation. Br J Radiol 1969;42:937-8.
39. Kinsella TJ, Sindelar WF, De Luca AM. Threshold dose for peripheral nerve injury following intraoperative radiotherapy (IORT) in a large animal model. Int J Radiat Oncol Biol Phys 1988;23:205.
40. Kirkpatrick JB. Pathogenesis of foam cell lesions in irradiated arteries. Am J Pathol 1967;50:291-309.
41. Kolar J. Strahlenfolgen am Herz und großen Gefäßen. Med Klin 1971;66:661-8.
42. Kovalic JJ. Perez CA. Radiation therapy following keloidektomie: a 20 year experience. Radiation oncology. Biol Phys 1989;17: 77-80.
43. Kramsch DM, Aspen AJ, Rozler LJ. Suppression of experimental atherosclerosis by the Ca++ antagonist lanthanum. J Clin Invest 1980;65:967-81.
44. Krüger A. Über Keloide und ihre Behandlung unter besonderer Berücksichtigung der Strahlentherapie. Strahlentherapie 1945; 93:426-33.
45. Laerum BF, Vlodaver Z, Castaneda-Zuniga WR, et al. The mechanism of angioplasty. Fortschr Röntgenstr 1982;136:573-6.
46. Le Couteur RA, Gilette EL, Powers BE, et al. Peripheral neuropathies following experimental intraoperative radiation therapy (IORT). Int J Radiat Oncol Biol Phys 1989;17:583-90.
47. Leclerc G, Isner JM, Kearny M, et al. Evidence implicating non-muscle myosin in restenosis. use of in situ hybridization to analyze human vascular lesions obtained by directional atherectomy. Circulation 1992;85:1-11.
48. Leung DYM, Glagov S, Matthews MB. Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro. Science 1976,191:475-7.
49. Levy DS, Salter MM, Roth RE. Postoperative irradiation in the prevention of keloids. Am J Roentg 1981;127:509-10.
50. Liermann D, Böttcher HD, Kollath J, et al. Intimai hyperplasia after stent implantation in peripheral arteries: treatment by endovascular afterloading. J Cardiovasc Intcrv Radiol 1994;17.1:12-6.
51. Liermann D, Schopohl B, Herrmann G, et al. Endovaskuläres Afterloading als Therapiekonzept zur Prophylaxe der intimalen Hyperplasie m peripheren Gefäßen nach Stentimplantation. In: Kollath J, Liermann D, eds. Stents II. Konstanz: Schnetztor, 1992:80-92.
52. Liu MW, Roubin GS, King SB. Restenosis after coronary angioplasty: potential biologic determinants and rose of intimai hyperplasia Circulation 1989;79:1374-87.
53. Liu MW, Roubin GS, Robinson KA. Trapidil in preventing restenosis after balloon-angioplasty in the atherosclerotic rabbit. Circulation 1990;81:1089-93.
54. Murphy JG, Schwartz RS, Kennedy K, et al. A new biocompatible polymeric coronary stent: design and early results in the pig model. J Am Coll Cardiol 1990;1:10.
55. Nabel EG, Plautz G, Nabel GJ. Site specific expression in vivo by direct gene transfer into the arterial wall. Science 1990;249: 1285-8.
56. Narayan K, Cliff WF. Morphology of irradiated microvasculature: a combined in vivo and electron microscopic study. Am J Pathol 1982;106:47-62.
57. Nilsson J, Sjölund M, Palmberg L, et al. Arterial smooth muscle cells in primary culture produce a platelet-derived growth factor like protein. Cell Biol 1985;82:4418-22.
58. Nobuyoshi M, Kimura T, Ohishi H, et al. Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. J Am Coll Cardiol 1991;176:433-9.
59. Ollstein RN, Siegel HW, Gilloley JF, et al. Treatment, of keloids by combined surgical excision and immediate postoperative x-ray therapy. Ann Plast Surg 1981;7:281-4.
60. Palmaz JC, Windeler SA, Garcia F. Atherosclerotic rabbit aortas: expandable intraluminal grafting. Radiology 1986;160:723-6.
61. Pepine CJ, Hirschfeld JW, MacDonald RG. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. Circulation 1990;81:1753-61.
62. Powell JS, Clozel JP, Müller KM. Inhibitors angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-8.
63. Reis GJ, Boucher TM, Sipperly ME. Randomized trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet 1989;2:1753-61.
64. Roeren T, Palmaz JC, Garcia O, et al. Percutaneous vascular grafting with a coated stent. Radiology 1990;177:1:202.
65. Rollins N, Wright KC, Charnsangavej C, et al. Self-expanding metallic stents: preliminary evaluation in an atherosclerotic model. Radiology 1987;163:739-42.
66. Rosen EM, Vinter DW, Goldberg ID. Hypertrophy of cultured bovine aortic endothelium following irradiation. Radiat Res 1989;117:395-408.
67. Rousseau H, Joffre F, Raillat C, et al. Self-expanding endovascular stent in experimental atherosclerosis. Radiology 1989; 170:773-8.
68. Scherer E, Streffer C, Trott KR, eds. Radiopathology of organs and tissues. Berlin: Springer, 1991.
69. Scherer E. Kontaktbestrahlung mit radioaktiven Stoffen. In: Handbuch der Medizinischen Radiologie, Bd XVI/2. Berlin-Heidelberg-New York: Springer, 1970:136-46.
70. Schwartz RS, Koval TM, Edwards WD, et al. Effect of external beam irradiation on neointimal hyperplasia after experimental coronary artery injury J Am Coll Cardiol 1992;19:1106-13.
71. Schwartz RS, Murphy JG, Edwards WD, et al. Restenosis occurs with internal elastic lamina laceration and its proportional to severity of vessel injury in a porcine coronary artery model. Circulation 1990;82:Suppl III:656.
72. Sholley MM, Gimbrone MA, Coltran RS. The effect of leukocyte depletion on corneal neovascularization. Lab Invest 1978;38:32-40.
73. Sholley MM, Gimbrone MA, Cotran RS. Cellular migration and replication in endothelial regeneration: a study using irradiated endothelial cultures. Lab Invest 1977;36:18.
74. Slepian MJ, Schindler A. Polymeric endoluminal paving/sealing: a biodegradable alternative to intracoronary stenting. Circulation 1988;78:409.
75. Spaet TH, Stemermann MB, Veith FJ, et al. Intimal injury and regrowth in the rabbit aorta. Medial smooth muscles cells as a source of neointima. Circ Res 1975;36:58-70.
76. Strecker EP, Hagen B, Licrmann D, et al. Komplikationen bei der Implantation arterieller Tantalstents und deren Behandlung. Zentralbl Radiol 1993;147:799.
77. Ueda M, Becker AE, Fujimoto T. Pathological changes induced by repeated percutaneous transluminal coronary angioplasty. Br Heart J 1987;58:635-43.
78. Wagner W, Schopohl B, Böttcher HD, et al. Ergebnisse der Narbenkeloidprophylaxe durch Kontaktbestrahlung mit Strontium 90. Röntgenpraxis 1989;42:248-52.
79. Wilcox JN. Analysis of local gene expression in human atherosclerotic plaques by in situ hybridization. Trends Cardiol Med 1991;1:17-24.
80. Zollikofer CL, Cragg AH, Hunter DW, et al. Mechanism of transluminal angioplasty. In: Castaneda-Zuniga WR, Tadavarthy SM, eds. Interventional radiology. Baltimore: Williams & Wilkins, 1992:249-98.